HER2-Targeting CAR-T Cells Show Highly Efficient Anti-Tumor Activity Against Glioblastoma Both In Vitro and In Vivo

Researchers constructed third-generation CAR-T cells targeting the HER2 antigen in glioblastoma. HER2-CAR-T cells showed effective anti-tumor activity both in vitro and in vivo.